Elanco Animal Health (NYSE: ELAN) reported Q1 EPS of $0.37, $0.06 better than the analyst estimate of $0.31. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.

GUIDANCE:

Elanco Animal Health sees FY2025 EPS of $0.80-$0.86, versus the consensus of $0.83. Elanco Animal Health sees FY2025 revenue of $4.51-4.58 billion, versus the consensus of $4.5 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.